Before revision: 37(2): 250-254 the use of cytokinin-meta-topolin (6-(3-Hydroxybenzylamino)purine) / ref > Aremu et al.
After revision: 37(2): 250-254 the use of cytokinin-meta-topolin (6-(3-Hydroxybenzylamino)purine) / 9< > Aremu et al.